What Is 7-OH (7-Hydroxymitragynine)? Risks, Withdrawal & Treatment
A medically reviewed guide to 7-OH effects, dependence, drug testing, and treatment on Long Island
Get Help for 7-OH
Speak confidentially with a Certified Recovery Peer Advocate serving Nassau and Suffolk County. Free, judgment-free, and available 24/7.
7-hydroxymitragynine, often called 7-OH, is a potent alkaloid that occurs naturally in small amounts in the kratom plant. It is now being sold in concentrated tablets, gummies, and shots that act much more like traditional opioids than ordinary kratom leaf.
This page provides a calm, medically reviewed overview of what 7-OH is, how dependence can develop, what withdrawal looks like, and what treatment options are available to residents of Nassau County, Suffolk County, and the broader Long Island region. It is informational and is not a substitute for the guidance of a qualified clinician.
What Is 7-Hydroxymitragynine (7-OH)?
7-OH is a minor alkaloid produced inside the leaves of Mitragyna speciosa, the kratom tree. While mitragynine is the most common alkaloid in kratom, 7-OH binds far more strongly to the brain's mu-opioid receptors. Recent products marketed as "7-OH" or "7-hydroxy" are concentrated forms — tablets, dissolvable strips, gummies, or shots — that contain much higher amounts than the leaf itself.
Common Product Forms
- • Tablets and capsules labeled "7-OH" or "7-hydroxy"
- • Dissolvable strips and lozenges
- • Liquid shots and concentrated extracts
- • Gummies and chewables
Concentrated 7-OH products may produce stronger and longer-lasting effects than traditional kratom powders or teas.
How 7-OH Differs From Traditional Kratom
Traditional kratom leaf products contain mostly mitragynine, with 7-OH appearing in trace amounts. Newer 7-OH products are intentionally concentrated, which changes the experience and the risk profile.
Because 7-OH activates opioid receptors more strongly, the experience can resemble traditional opioids in both effect and dependence pattern. People who tolerate traditional kratom without issue may still develop problems with concentrated 7-OH.
Signs of 7-OH Dependence
Use can become problematic when a person relies on 7-OH to feel normal, manage stress, or avoid discomfort. Early signs of dependence may include:
- • Needing larger or more frequent doses to feel the same effect
- • Feeling sick, anxious, or restless between doses
- • Difficulty cutting back even when wanting to
- • Using 7-OH to handle daily routines, sleep, or emotions
- • Spending significant time or money obtaining 7-OH products
If these patterns sound familiar, speaking with a clinician trained in substance use can help clarify next steps without pressure or judgment.
7-OH Withdrawal Symptoms and Timeline
Withdrawal from 7-OH typically resembles opioid withdrawal. Symptoms can range from mild to uncomfortable depending on the dose, frequency, and duration of use.
Common Physical Symptoms
- • Muscle aches and joint pain
- • Sweating and chills
- • Runny nose and watery eyes
- • Stomach upset, nausea, or diarrhea
- • Insomnia and disrupted sleep
Common Emotional Symptoms
- • Irritability and restlessness
- • Anxiety
- • Low mood or sadness
- • Difficulty concentrating
- • Strong cravings
Symptoms usually begin within 12 to 24 hours after the last dose, peak around days 2 to 3, and improve over about a week. Mood changes and cravings may last longer.
Health Risks to Be Aware Of
Because 7-OH acts strongly on opioid receptors, it carries some of the same risks as traditional opioids:
- • Slowed breathing at high doses, especially when combined with alcohol, benzodiazepines, or other opioids
- • Tolerance that builds quickly with regular use
- • Withdrawal that can interfere with work, school, and family life
- • Variability between products, since 7-OH content is not standardized
Naloxone (Narcan) may help reverse opioid-like effects in an emergency. Always call 911 if someone is unresponsive or struggling to breathe.
Is Medical Detox Needed?
Medical detox is not required for everyone, but it can be helpful for people who:
- • Use high daily amounts of 7-OH
- • Combine 7-OH with other substances
- • Have severe physical or emotional withdrawal symptoms
- • Live with co-occurring medical or mental health conditions
A clinical assessment can determine whether supervised detox or supportive outpatient care is the better fit.
Treatment Options on Long Island
Residents of Nassau and Suffolk County have access to several evidence-based options for 7-OH dependence. Care typically focuses on comfort, stability, and long-term recovery.
Outpatient and Intensive Outpatient Programs
Flexible care for people who want support while keeping daily routines. May include individual counseling, group therapy, relapse-prevention work, and family involvement. Learn more about IOP.
Medication-Assisted Treatment (MAT)
Because 7-OH activates opioid receptors, clinicians may consider MAT options such as buprenorphine to ease withdrawal and stabilize cravings, depending on individual assessment.
Inpatient or Residential Care
Helpful for people who need a structured environment, additional medical monitoring, or distance from triggers. See inpatient programs.
Peer Support and Recovery Coaching
Certified Recovery Peer Advocates (CRPAs) can help with understanding treatment options, navigating insurance, connecting to local resources, and ongoing encouragement.
Evidence and Uncertainty
Scientific research on 7-OH is still evolving. Animal and laboratory studies suggest meaningful potential for dependence, but large human studies are limited. Regulators including the FDA have raised concerns about concentrated 7-OH products, and international addiction-prevention groups continue to track new findings.
Helpful background reading from independent sources:
- • ISSUP: 7-OH overview and prevention guidance
- • FDA: Kratom and 7-OH advisory information
- • NIDA: Kratom drug facts
For a deeper look at how 7-OH is being categorized in current policy discussions, see our companion article: 7-OH Drug Classification.
Local Resources for Long Island
Supportive resources across Nassau and Suffolk County may include:
- • Community mental-health clinics
- • OASAS-certified outpatient programs
- • Hospital-based addiction services
- • Peer support and harm-reduction networks
- • Primary care clinicians familiar with substance-use care
These resources can help individuals explore options and learn more about 7-OH and other kratom-related products.
Frequently Asked Questions
Need Support?
If you live in Nassau or Suffolk County and want to understand your options around 7-OH or kratom dependence, our Certified Recovery Peer Advocates can offer confidential guidance and connect you with local, OASAS-certified resources.
There is no pressure or obligation to begin treatment.
Call 844-338-6969 for confidential supportMedical References & Sources
This page contains information sourced from peer-reviewed medical literature, federal health agencies, and accredited medical institutions to ensure accuracy and compliance with E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) standards.
- U.S. Food and Drug Administration (FDA). "FDA warns consumers not to use 7-hydroxymitragynine (7-OH) products." FDA Safety Communication, 2025. Available at: https://www.fda.gov/consumers/consumer-updates/fda-warns-not-use-kratom
- Kruegel, A.C., Uprety, R., Grinnell, S.G., et al.. "7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects." ACS Central Science, 2019 DOI: 10.1021/acscentsci.9b00141. Available at: https://doi.org/10.1021/acscentsci.9b00141
- Váradi, A., Marrone, G.F., Palmer, T.C., et al.. "Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism." Journal of Medicinal Chemistry, 2016 DOI: 10.1021/acs.jmedchem.6b00748. Available at: https://doi.org/10.1021/acs.jmedchem.6b00748
- National Institute on Drug Abuse (NIDA). "Kratom DrugFacts." NIH. Available at: https://nida.nih.gov/publications/drugfacts/kratom
- Drug Enforcement Administration (DEA). "Kratom Drug Fact Sheet." DEA Diversion Control Division. Available at: https://www.dea.gov/factsheets/kratom
- Zohar, B.. "What Is 7-OH? The Emerging Opioid Threat Addiction Professionals Need to Understand in 2026." ISSUP. Available at: https://www.issup.net/node/33941
- Zohar, B.. "7-OH Withdrawal: Symptoms, Timeline, and Treatment." ISSUP. Available at: https://www.issup.net/node/32674
Medical Disclaimer
The information provided on this page is for educational purposes only and should not be considered medical advice. This page does not provide medical diagnoses, treatment prescriptions, or clinical recommendations. Always consult with qualified healthcare professionals for diagnosis and treatment of substance use disorders. If you are experiencing a medical emergency, call 911 immediately.
This content was written by certified addiction professionals and reviewed by licensed medical practitioners to ensure accuracy and adherence to current clinical guidelines. Last fact-checked: July 11, 2026.
If you or someone you know is struggling with substance use, you can reach our 24/7 confidential Long Island Rehab Helpline at 844-338-6969 for free, confidential information and treatment referral.